Kawashima T - Search Results

1

Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.

Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H. Shobugawa Y, et al. Among authors: kawashima t. J Infect Chemother. 2012 Dec;18(6):858-64. doi: 10.1007/s10156-012-0428-1. Epub 2012 May 29. J Infect Chemother. 2012. PMID: 22644080 Clinical Trial.

2

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.

Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Maeda T, Miyachi K, Hirotsu N, Shigematsu T, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. Clin Infect Dis. 2005 May 1;40(9):1309-16. doi: 10.1086/429241. Epub 2005 Mar 16. Clin Infect Dis. 2005. PMID: 15825034

3

Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.

Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. J Infect. 2007 Sep;55(3):267-72. doi: 10.1016/j.jinf.2007.05.176. Epub 2007 Jul 2. J Infect. 2007. PMID: 17604839

4

High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.

Saito R, Li D, Suzuki Y, Sato I, Masaki H, Nishimura H, Kawashima T, Shirahige Y, Shimomura C, Asoh N, Degawa S, Ishikawa H, Sato M, Shobugawa Y, Suzuki H. Saito R, et al. Among authors: kawashima t. J Med Virol. 2007 Oct;79(10):1569-76. doi: 10.1002/jmv.20946. J Med Virol. 2007. PMID: 17705168

5

A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kanazawa H, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Nagai T, Horii S, Hirotsu N, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. J Infect. 2008 Jan;56(1):51-7. doi: 10.1016/j.jinf.2007.09.002. Epub 2007 Oct 15. J Infect. 2008. PMID: 17936910 Clinical Trial.

6

A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan.

Kawai N, Ikematsu H, Iwaki N, Kawamura K, Kawashima T, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. J Infect Chemother. 2007 Oct;13(5):314-9. doi: 10.1007/s10156-007-0538-3. Epub 2007 Oct 30. J Infect Chemother. 2007. PMID: 17982720

7

Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan.

Saito R, Suzuki Y, Li D, Zaraket H, Sato I, Masaki H, Kawashima T, Hibi S, Sano Y, Shobugawa Y, Oguma T, Suzuki H. Saito R, et al. Among authors: kawashima t. J Infect Dis. 2008 Feb 15;197(4):630-2; author reply 632-3. doi: 10.1086/525055. J Infect Dis. 2008. PMID: 18275281 No abstract available.

8

Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. J Infect. 2009 Sep;59(3):207-12. doi: 10.1016/j.jinf.2009.07.002. Epub 2009 Jul 7. J Infect. 2009. PMID: 19619898

9

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424. Clin Infect Dis. 2009. PMID: 19911968

10

Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Iwakuni O, Egashira K, Yamaji K, Kashiwagi S. Kawai N, et al. Among authors: kawashima t. J Infect Chemother. 2012 Apr;18(2):180-6. doi: 10.1007/s10156-011-0314-2. Epub 2011 Dec 23. J Infect Chemother. 2012. PMID: 22193710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,229 results

Search Page